Nina Hartman, MD
Procedural Dermatology · Washington, DCNPI 1407380967
Payments from drug & device makers
Across 98 payments — averaging $103.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merz North America, Inc.$8K
- AbbVie$692
- Galderma Laboratories, L.p.$272
- Sanofi$191
- Regeneron Healthcare Solutions, Inc.$164
- Ortho Dermatologics, A Division Of Bausch Health US, LLC$128
- plus $579 from 12 others
What the payments were for
- Consulting fees$8,10980%
- Food & beverage$1,94719%
- Education$801%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merz North America, Inc. | 2 | $8,109 |
| AbbVie | 38 | $692 |
| Galderma Laboratories, L.p. | 12 | $272 |
| Sanofi | 9 | $191 |
| Regeneron Healthcare Solutions, Inc. | 7 | $164 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 7 | $128 |
| Incyte Corporation | 5 | $114 |
| Sanofi-aventis U.S. LLC | 1 | $80 |
| Amgen | 3 | $70 |
| Journey Medical Corporation | 3 | $65 |
| Sun Pharmaceutical Industries Inc. | 2 | $47 |
| Biofrontera Inc. | 1 | $43 |
| UCB, Inc. | 2 | $37 |
| Dermavant Sciences, Inc. | 2 | $34 |
| Mayne Pharma Commercial LLC | 1 | $28 |
| LEO Pharma Inc. | 1 | $23 |
| Revance Therapeutics, Inc. | 1 | $23 |
| Pfizer | 1 | $15 |
How this compares
Too few procedural dermatology providers in District of Columbiato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 34 | $1,010 |
| Ketoconazole | 22 | $346 |
| Minoxidil | 24 | $327 |
| Doxycycline Monohydrate | 14 | $230 |
| Triamcinolone Acetonide | 19 | $217 |
| Hydrocortisone | 26 | $97 |
Paid to pharmacies, not to this prescriber.
Other procedural dermatology in Washington
- Cheryl BurgessWashington$2.4M
- Sara HoganWashington$32K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.